Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma

Fig. 3

The predicted clearance of patients treated with everolimus (comparator arm of CheckMate 025), via the prognostic cytokine signature, was associated with OS. OS overall survival, predicted high CL patients predicted to have high clearance from the cytokine signature, predicted low CL patients predicted to have low clearance from the cytokine signature

Back to article page